Cochlear reported $820.7M in Sales Revenues for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ansell ANN:AU $ 1.01B 79.9M
Cochlear COH:AU $ 820.7M 66.3M
CSL CSL:AU $ 6.04B 1.47B
Estia Health EHE:AU $ 341.62M 17.81M
Fisher Paykel Healthcare FPH:NZ 900M 161M
Healius Ltd HLS:AU $ 1.34B 389.5M
Integral Diagnostics Ltd IDX:AU 178.95M 7.2M
Japara Healthcare JHC:AU 206.85M 5.83M
Mayne Pharma MYX:AU $ 196.8M 4.78M
Monash IVF Group Ltd MVF:AU 100.98M 8.14M
Nanosonics Ltd NAN:AU $ 60.65M 715K
Opthea Ltd OPT:AU 91.22K 336.9K
Polynovo Ltd PNV:AU 18.1M 1.54M
Regis Healthcare REG:AU 395.6M 11.98M
ResMed RMD:AU $ 894.87M 18.77M
Sigma Healthcare Ltd SIG:AU 1.79B 26M
Somnomed Ltd SOM:AU 33.93M 2.05M
Sonic Healthcare SHL:AU $ 4.76B 434.64M
Telix Pharmaceuticals Ltd TLX:AU 4.69M 1.78M
Virtus Health VRT:AU 171.3M 16.31M